One expert in Indiana expects to see another wave of COVID-19 infections during late spring based on past patterns.

Arcturus Therapeutics ARCT and partner CSL Seqirus, a renowned vaccine company, together reported encouraging results from a ...

The updated formulation pertains to both approved (Comirnaty and Spikevax) and authorized (Moderna COVID-19 Vaccine and Pfizer-BioNTech COVID-19 Vaccine) mRNA vaccines. The 2024-2025 mRNA COVID-19 ...

Provides updates on BioNTech’s strategy to scale and deploy AI-capabilities across the immunotherapy pipelineHighlights InstaDeep’s new near ...

AbbVie Humira, Pfizer/BioNTech COVID-19 shot may not make top 10 pharma drugs in 2024, with Novo Nordisk Ozempic and ...

The Biden administration has relaunched its program sending free COVID-19 tests in the mail.{beacon} Health Care Health Care ...

The BioNTech SE ADR BNTX inched 0.49% higher to $118.22 Friday, on what proved to be an all-around mixed trading session for ...

Along with the annual flu vaccine, the new COVID-19 vaccine formulation is now widely available in Minnesota. It comes at a ...

A federal judge in Washington D.C. cited the government’s “general immunity” in dismissing a lawsuit that accused the ...

Pfizer is removing its Oxbryta pill for sickle cell disease from all markets globally due to safety risks, including deaths.

In July, a High Court judge delivered a mixed ruling in the long-running dispute that has pitted pharmaceutical giant Pfizer ...